Arcus Biosciences Inc (RCUS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RCUS Annual Balance Sheets →
Examining balance sheet movements between Arcus Biosciences Inc and Mar 31 2025 reveals how Mar 31 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent201.00
Cash, Cash Equivalents Other0.00
Available-for-sale Securities, Debt Securities, Current MA621.00
Short-term Investments0.00
Cash & Short-term Investments822.00
Interest Receivable, Current0.00
Other Current Assets3.00
Prepaid Expense And Other Assets Current19.00
Total Current Assets844.00
Equipment/Property/Plant Net38.00
Long-term investments54.00
Other Assets, Noncurrent61.00
Contract With Customer Asset Net Current3.00
Total Assets997.00
Liabilities
Accounts Payable, Current AC39.00
Accrued Liabilities, Current AC0.00
Other Liabilities, Current170.00
Total Current Liabilities209.00
Long-term debt100.00
Total Long-term Debt100.00
Contract With Customer Liability Current34.00
Contract With Customer Liability Noncurrent45.00
Total Liabilities473.00
Stockholders' Equity
Common Stock Value2,138.00
Retained Earnings / Accumulated Deficit-1,613.00
Other Equity-1.00
Common Stockholder's Equity524.00
Total Stockholder's Equity524.00
Liabilities & Stockholder's Equity997.00
4 historic quarters locked

Sign in to unlock the full Arcus Biosciences Inc balance sheet history.

About Arcus Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001724521-26-000044

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.